A critical appraisal of atomoxetine in the management of ADHD
Ann C ChildressCenter for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USAAbstract: Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder beginning in childhood and often continuing into adulthood. A wealth of data shows that ADHD symptoms respond well to p...
Main Author: | Childress AC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-12-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/a-critical-appraisal-of-atomoxetine-in-the-management-of-adhd-peer-reviewed-article-TCRM |
Similar Items
-
Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01) -
Effectiveness and safety of atomoxetine for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01) -
Probable emergence of symptoms of trichotillomania by atomoxetine: a case report
by: Hamza Ayaydın
Published: (2019-04-01) -
Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
by: Shiho Suzuki, et al.
Published: (2020-05-01) -
Atomoxetine associated red ear: A case report (eng)
by: Hande Ayraler Taner, et al.
Published: (2020-04-01)